Literature DB >> 18544962

Cancer stem cells in breast: current opinion and future challenges.

Emmanuelle Charafe-Jauffret1, Florence Monville, Christophe Ginestier, Gabriela Dontu, Daniel Birnbaum, Max S Wicha.   

Abstract

There is increasing evidence for the cancer stem cell hypothesis, which holds that cancers are driven by a cellular subcomponent that has stem cell properties, that is, self-renewal, tumorigenicity and multilineage differentiation capacity. The cancer stem cell hypothesis modifies our conceptual approach of oncogenesis and shall have implications in breast cancer prevention, detection and treatment, especially in metastatic breast cancer for which no curative treatment exists. Given the specific stem cell features, novel therapeutic pathways can be targeted. Following this approach, new molecules are currently in development. Focusing on the cross-talk between stem cells and their microenvironment is also a promising way to explore how to better target cancer stem cells and be curative. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544962      PMCID: PMC2789397          DOI: 10.1159/000123845

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  73 in total

1.  Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation.

Authors:  Marie-Liesse Asselin-Labat; Kate D Sutherland; Holly Barker; Richard Thomas; Mark Shackleton; Natasha C Forrest; Lynne Hartley; Lorraine Robb; Frank G Grosveld; Jacqueline van der Wees; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

2.  Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo.

Authors:  Corinne A Boulanger; David L Mack; Brian W Booth; Gilbert H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

3.  Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia.

Authors:  Steven M Chan; Andrew P Weng; Robert Tibshirani; Jon C Aster; Paul J Utz
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

4.  HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.

Authors:  Virginie Clement; Pilar Sanchez; Nicolas de Tribolet; Ivan Radovanovic; Ariel Ruiz i Altaba
Journal:  Curr Biol       Date:  2006-12-28       Impact factor: 10.834

5.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 6.  [Towards an integrated cellular and molecular: definition of breast cancers].

Authors:  Emmanuelle Charafe-Jauffret; Max Chaffanet; François Bertucci; Christophe Ginestier; Jocelyne Jacquemier; Odile deLapeyrière; Daniel Birnbaum
Journal:  Med Sci (Paris)       Date:  2007 Jun-Jul       Impact factor: 0.818

7.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

8.  Molecular definition of breast tumor heterogeneity.

Authors:  Michail Shipitsin; Lauren L Campbell; Pedram Argani; Stanislawa Weremowicz; Noga Bloushtain-Qimron; Jun Yao; Tatiana Nikolskaya; Tatiana Serebryiskaya; Rameen Beroukhim; Min Hu; Marc K Halushka; Saraswati Sukumar; Leroy M Parker; Karen S Anderson; Lyndsay N Harris; Judy E Garber; Andrea L Richardson; Stuart J Schnitt; Yuri Nikolsky; Rebecca S Gelman; Kornelia Polyak
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

9.  Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.

Authors:  Laura G Fulford; Jorge S Reis-Filho; Ken Ryder; Chris Jones; Cheryl E Gillett; Andrew Hanby; Douglas Easton; Sunil R Lakhani
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.

Authors:  Gillian Farnie; Robert B Clarke; Katherine Spence; Natasha Pinnock; Keith Brennan; Neil G Anderson; Nigel J Bundred
Journal:  J Natl Cancer Inst       Date:  2007-04-18       Impact factor: 13.506

View more
  70 in total

1.  The biology of incipient, pre-invasive or intraepithelial neoplasia.

Authors:  William E Grizzle; Sudhir Srivastava; Upender Manne
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  Shambhunath Choudhary; Shilpa Sood; Robert L Donnell; Hwa-Chain R Wang
Journal:  Carcinogenesis       Date:  2012-02-03       Impact factor: 4.944

3.  Specific posttranslational modification regulates early events in mammary carcinoma formation.

Authors:  Hua-Bei Guo; Heather Johnson; Matthew Randolph; Tamas Nagy; Ryan Blalock; Michael Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

4.  Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells.

Authors:  Irida Kastrati; Loruhama Delgado-Rivera; Gergana Georgieva; Gregory R J Thatcher; Jonna Frasor
Journal:  J Vis Exp       Date:  2017-01-18       Impact factor: 1.355

5.  Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

Authors:  So Yeon Park; Hee Eun Lee; Hailun Li; Michail Shipitsin; Rebecca Gelman; Kornelia Polyak
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

6.  Identification of CD44+CD24+ gastric cancer stem cells.

Authors:  Chaojun Zhang; Chenwei Li; Fengtian He; Yujiao Cai; Hua Yang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-01       Impact factor: 4.553

7.  Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.

Authors:  Refael Peleg; Marianna Romzova; Inga Kogan-Zviagin; Ron N Apte; Esther Priel
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

8.  Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.

Authors:  Abhik Bandyopadhyay; Long Wang; Joseph Agyin; Yuping Tang; Shu Lin; I-Tien Yeh; Keya De; Lu-Zhe Sun
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

9.  Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Authors:  Bahriye Aktas; Mitra Tewes; Tanja Fehm; Siegfried Hauch; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Breast Cancer Res       Date:  2009-07-09       Impact factor: 6.466

10.  The cancer stem cell concept in progression of head and neck cancer.

Authors:  Zhuo Georgia Chen
Journal:  J Oncol       Date:  2009-12-03       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.